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Abstract 
Pluripotent stem cells are the starting cell type of choice for the development of many cell-based regenerative 
therapies due to their rapid and unlimited proliferation and broad differentiation potential. The unique pluripotent 
cell cycle underlies both these properties. Hyperpolarization-activated cyclic nucleotide-gated cation (HCN) family 
channels have previously been reported to modulate mouse embryonic stem cell (ESC) proliferation and here we 
characterize the effects of HCN inhibitor ZD7288 on ESC proliferation and stem cell identity. The doubling time of 
cells treated with the HCN blocker increased by ~30 % due to longer G1 and S phases, resulting in a nearly twofold 
reduction in ESC numbers after 4 day serum-free culture. Slower progression through S phase was not accompanied 
by H2AX phosphorylation or cell stalling at transition points, although EdU incorporation in treated cells was reduced. 
Despite the drastic cell cycle perturbations, the pluripotent status of the cells was not compromised by treatment. 
Cultures treated with the HCN blocker in maintenance conditions maintained pluripotency marker expression on 
both RNA and protein level, although we observed a reversible effect on morphology and colony formation fre-
quency. Addition of ZD7288 in differentiating media improved FBS-driven differentiation, but not directed differentia-
tion to neuroectoderm, further indicating that altered cell cycle structure does not necessarily compromise pluripo-
tency and drive ESCs to differentiation. The categorically different outcomes of ZD7288 use during differentiation 
indicate that cell culture context can be determinative for effects of ion-modulatory molecules and underscores the 
need for exploring their action in serum-free conditions demanded by potential clinical use.
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Background
As we draw closer to fulfilling the promise of regenera-
tive medicine, more and more cell therapy techniques 
are relying on a pluripotent cell source (Tabar and Studer 
2014). Whether embryonic stem cells (ESCs) or induced 
pluripotent stem cells (iPSCs) are used, their capacity to 
generate any cell type in the adult body, together with 
their unlimited and robust proliferation, present both the 
main advantages and some of the greatest challenges to 
therapy development. These properties are harnessed and 
kept in check by culture in specific conditions, permissive 
and instructive of timely differentiation to the desired cell 
types. Clinical use of the resulting cells puts additional 
requirements on protocol development, such as the use 
of well-defined serum-free media components. Balanc-
ing the many biological and regulatory requirements on 
Open Access
*Correspondence:  michael.andang@ki.se 
1 Department of Physiology and Pharmacology, Karolinska Institutet,  
171 77 Stockholm, Sweden
Full list of author information is available at the end of the article
Page 2 of 10Omelyanenko et al. SpringerPlus  (2016) 5:41 
differentiation strategies makes understanding of the 
underlying stem cell biology and the interplay between 
stem cell properties and culture conditions essential to 
success in bringing forward new cell-based therapies.
The cell cycle of embryonic stem cells is characterized 
by a lack of a G0 and shortened G1 and G2 phases. This 
has major implications for the underlying regulatory net-
work, as most conventional regulatory factors, which 
cycle during cell cycle progression in differentiated cell 
types do so to a significantly lower extent in embryonic 
stem cells. ESCs lack hypophosphorylated RB protein 
(Savatier et  al. 1994), show constitutive CDK2, cyclin A 
and cyclin E activity (Stead et  al. 2002), lower APC/C 
activity (Ballabeni et al. 2011), and constitutively express 
geminin (Yang et al. 2011). Altogether, these biochemical 
characteristics of ESCs lead to a shortened G1 and G2. 
Pluripotent cells also respond differently to damage path-
way induction, by, for example, failing to upregulate p21 
in response to DNA damage-induced p53 accumulation, 
which leads to downregulation of Nanog and differentia-
tion, instead of G1/S cell cycle arrest (Hyka-Nouspikel 
et al. 2012; Lin et al. 2005).
There is a strong link between cycling and mainte-
nance of stem cell identity, as differentiation is invari-
ably accompanied by a lengthening of the cell cycle, 
and reprogramming, conversely, by its shortening (Li 
and Kirschner 2014). This variability in transit time is 
accounted for by lengthening of the gap phases, G1 and 
G2, while S and M phases are similar in length in pluri-
potent and differentiated cells (Stead et  al. 2002; Chen 
et al. 2015b). G1 in particular has received a lot of atten-
tion, with early work showing that embryonal carcinoma 
cells are only responsive to retinoic acid differentiation 
while in G1 (Mummery et al. 1987). Since then, a shorter 
G1 was tied to self-renewal (Becker et  al. 2006) and 
improved reprogramming capacity (Ruiz et al. 2011; Guo 
et al. 2014). The initial observation gained fresh backing 
with recent RNA sequencing studies showing that differ-
entiation and lineage specification transcription factors 
are preferentially transcribed in G1 (Singh et  al. 2013). 
Intriguingly, interfering with the cell cycle, most often 
through CDK2 inhibition, has showed varying effects on 
differentiation and self-renewal. While lengthening G1 
with small molecule inhibition of CDK2 has resulted in 
impaired self-renewal in some studies (Koledova et  al. 
2010), other studies using different small molecule CDK2 
inhibitors or overexpression of p21 and p27, native CDK2 
inhibitors, failed to show similar effects (Li et  al. 2012; 
Stead et al. 2002).
We and others (Andang et  al. 2008a; Lau et  al. 2011; 
Rodriguez-Gomez et  al. 2012) have previously reported 
that modulation of ion fluxes in embryonic stem cells can 
induce alterations in proliferation kinetics  with varying 
effects on stem cell fate. While knockout of GABAA 
beta3 subunit, which reduced ESC proliferation in vitro, 
results in viable mice (Liljelund et  al. 2005), suggest-
ing that stem cell potential is not compromised in the 
absence of GABA signalling, inhibition of T-type calcium 
channels slows down proliferation and induces prema-
ture ESC differentiation (Rodriguez-Gomez et  al. 2012). 
In a 2011 study by Lau et  al. (Lau et  al. 2011) block of 
the hyperpolarization-activated cyclic nucleotide-gated 
cation channel (HCN) family was found to slow down 
mESC proliferation, however the impact this had on 
pluripotency maintenance was not investigated.
The HCN family of channels consists of four mem-
bers with varying tissue expression patterns (Calejo et al. 
2014) and gating and activation kinetics (Biel et al. 2009). 
HCN1, 2 and 4 have been extensively studied for their 
functions in rhythm generation and regulation of mem-
brane polarization in neurons and the sinoatrial node, 
whereas the function of HCN3 is less clear (DiFrancesco 
and DiFrancesco 2015). HCN3, which is widely expressed 
over the entire organism at low levels, was the only HCN 
family member found to be expressed on a protein level 
in ESCs (Lau et  al. 2011). The channel activates at volt-
ages negative of resting membrane potential and initiates 
repolarization, with opening and closing kinetics vary-
ing depending on intracellular cAMP levels. In this work 
we looked more closely at the effect of ZD7288, a widely 
used tool compound for modulation of the HCN current, 
on the ESC cell cycle and characterized the previously 
uninvestigated effects of this compound on stem cell fate.
Results
ZD7288, an HCN channel blocker, reduces ES cell 
proliferation by increasing doubling time
When ES cells were cultured in the presence of an HCN 
blocker (ZD7288), cell proliferation was significantly 
reduced with a nearly twofold reduction in cell numbers 
after 4 days of culture (7.9 ±  1.2 ×  105 cells/ml control 
culture, 3.5 ± 0.5 × 105 cells/ml treated culture, p < 0.01), 
and only a small (87.4 ±  1.4  % control vs 80.1 ±  1.8  % 
treated, p < 0.01) reduction in viability (Fig. 1a, b). Col-
ony size was correspondingly reduced when cells were 
grown at subclonal densities, decreasing from an aver-
age of 44 to 27 cells per colony (43.8 ± 6.2 cells/colony in 
control, 27.0 ± 3.5 cells/colony in treated, p < 0.05) 5 days 
after plating (Fig.  1c). Doubling time, which was ~28  h 
for untreated bulk cells [in line with previously published 
findings for this culture system (Tamm et al. 2013)], was 
increased to ~37 h for ZD7288 treated cells (Fig. 1d).
Since the slight reduction in viability could not account 
for the drastically reduced cell count, we looked for possible 
alterations in cell cycle phase distribution due to ZD7288 
treatment. The G0 phase is usually absent from the ESC cell 
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cycle and positive KI-67 staining indicated that this is also 
the case for ZD7288 treated cells (Fig. 1e). To look at the 
phases of the active cell cycle we performed flow cytometry 
for DNA content. We observed a significant increase in S 
phase upon ZD7288 treatment (37.6 % in control, 41.8 % 
in treated, p < 0.01), which is in agreement with the find-
ings of Lau et al. (2011), even though the two studies were 
carried out under different conditions. In contrast to Lau’s 
findings, where the fraction of cells in G1 was reduced and 
of those in G2/M unchanged, we saw that the increase in 
the S phase fraction was accompanied by a reduction in the 
G2/M compartment (28.3 % in control, 23.4 % in treated, 
p < 0.001) (Fig. 1f). Using the calculated doubling time and 
cell cycle fractions, we calculated the time spent in each of 
the phases. In our hands, both G1 and S phases of the cell 
cycle were extended due to ZD7288 treatment, whereas 
analysis of data from Lau et  al. indicated an appreciable 
increase in the length of S phase only (Fig. 1g, h).
DNA replication in S phase is altered in ZD7288 treated 
cells
It has previously been shown that gamma-aminobutyric 
acid (GABA) can induce proliferative arrest in ESCs via a 
DNA-damage-independent induction of the DNA damage 
response (DDR) pathway and histone H2AX phosphoryla-
tion (Andang et al. 2008a). Since both ZD7288 and GABA 
are expected to influence ion fluxes, affecting membrane 
polarization dynamics, they may activate common down-
stream pathways to attenuate proliferation. To test this we 
performed flow cytometry and immunohistochemistry for 
γH2AX, but did not find increased histone phosphoryla-
tion levels in treated cells (Fig. 2a, b).
To examine the alterations in S-phase, cells were 
pulsed with EdU to allow observation of nucleotide 
incorporation during DNA replication. When we looked 
at nucleotide incorporation using flow cytometry, fewer 
cells in the blocked culture were deemed EdU posi-
tive (37.3  ±  2.4  % in control, 19.7  ±  3.6  % in treated, 
p  <  0.05), despite a larger fraction of cells being in the 
S-phase based on DNA content (see Fig.  1f ). This was 
due to much lower EdU incorporation levels in the HCN-
blocked cells resulting in a completely altered EdU incor-
poration profile. Whereas control cells showed two clear 
peaks corresponding to EdU incorporating and non-
incorporating cells, all ZD7288 treated cells fell within a 
single wide peak (Fig. 2c, d). The observed change in EdU 
incorporation profile could be due to stalling at a par-
ticular point within S-phase, slower DNA replication, or 
reduced EdU availability.
To investigate potential accumulation of cells at a par-
ticular point in S-phase, we looked at the distribution of 
cells between early and late S phase using a previously 
described method where cells are staged based on EdU 
incorporation pattern (Solovei et  al. 2006). The sub-S 
phase distribution was not affected, with 55.7 ±  10.5  % 
of cells in early S in the control condition and 53.3 ± 6. 
0  % in early S in ZD7288 treated cultures (Fig.  2d, e). 
This indicated that in the presence of the HCN inhibitor, 
cells continue replicating DNA and progressing through 
S-phase, while reduced EdU incorporation suggests that 
this process occurs at a slower rate than in control condi-
tions, supporting our findings of a longer S-phase.
Treatment with ZD7288 decreased colony formation 
frequency but did not alter expression of the core 
pluripotency genes
To examine effects of HCN inhibitor treatment and sub-
sequent cell cycle lengthening on ESC self-renewal in 
maintenance media, ESCs were plated at subclonal den-
sity and allowed to form colonies for 4 days in the pres-
ence or absence of ZD7288. Although ALP expression 
was not altered, colony numbers were reduced upon 
treatment (Fig. 3a), and fraction of ALP positive colonies 
with rugged edges increased (Fig.  3b). To investigate if 
these effects on morphology were accompanied by loss 
of pluripotency, we looked at expression of pluripotency 
markers by qPCR and immunohistochemistry. qPCR 
analysis showed no significant differences in pluripo-
tency marker expression between treated and untreated 
cells (Fig. 3c), suggesting that altered colony morphology 
was not due to differentiation. This was confirmed on the 
protein level, with colonies staining positive for SSEA1, 
OCT4, SOX2 and NANOG (Fig. 3d) in both culture con-
ditions. To further indicate that the self-renewal potential 
of the ESCs was not compromised, the relative ratio of 
rugged and smooth colonies was restored when ZD7288 
(See figure on previous page.) 
Fig. 1 Blocker of HCN family channels, ZD7288, reduces ESC proliferation by lengthening the G1 and S phases of the cell cycle. Culture in the pres-
ence of 10 μM HCN inhibitor ZD7288 resulted in reduced mESC cell numbers after 4 days in suspension (Student’s t-test; p < 0.01; n = 9) (a) with a 
minimal reduction in viability (Student’s t-test; p < 0.05; n = 9) (b). Cells cultured adherently at subclonal densities formed smaller colonies (Mann 
Whitney test; p < 0.05; n = 3) (c). Despite a significantly longer doubling time (sum of squares f-test; p < 0.05; n = 9) (d) the cells did not exit the 
cell cycle, as indicated by ubiquitous KI-67 expression in both control and treated cultures (e). Flow cytometry for DNA content (f) showed an accu-
mulation of cells in the S phase (Student’s t-test; p < 0.01; n = 3), and a relative reduction in the number of cells in G2/M (Student’s t-test; p < 0.01; 
n = 3). Doubling time and cell cycle fraction were used to calculate residence time in each cell cycle phase for control cultures and cultures treated 
with 10 μM ZD7288 (g). Comparison of cell cycle structure in our study and previous study by Lau et al. is summarized in (h)
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treated cells were replated and allowed to form colonies 
in ZD7288-free media (data not shown).
HCN inhibitor ZD7288 affects ES cell differentiation 
outcomes in a context‑dependent manner
In addition to self-renewal, the ability to differentiate 
into the 3 germ layers is a critical property of ESCs. To 
investigate how this property was affected by treatment, 
we looked at differentiation potential under unbiased 
conditions and during directed differentiation with and 
without ZD7288.
To test differentiation under unbiased conditions, ESCs 
were plated on laminin in FBS containing media with-
out LIF supplementation in the presence or absence of 
ZD7288. qPCR for differentiation and pluripotency genes 
5 days following induction of FBS differentiation showed 
that ZD7288 treated cells upregulated lineage genes spe-
cific for the 3 germ layers and extraembryonic endoderm 
(Fig.  4b) to a significantly higher degree than cells dif-
ferentiated in the absence of the compound. Concomi-
tantly, pluripotency-specific genes were downregulated 
to a significantly greater extent in treated culture, with 
the exception of Oct4, which was expressed at higher lev-
els (Fig.  4a), consistent with extraembryonic endoderm 
induction (Wang et al. 2012).
Surprisingly, when directed differentiation towards the 
neural lineage was induced by culturing cells in LIF free 
media supplemented with B27, we did not see improved 
differentiation under ZD7288 treatment conditions, as 
was observed with unbiased differentiation. There were 
no significant differences in expression of most pluripo-
tency markers (Fig.  4c) between control and ZD7288-
treated conditions, and no significant increase in 
expression of most differentiation markers (Fig. 4d) in the 
HCN block condition. In the case of neural markers, of 
the 3 markers tested two, Otx2 and Fgf8, were expressed 
at significantly lower levels in the treated cells than con-
trol, and the only significantly downregulated pluripo-
tency marker was Sox2, which was expected to be high 
in neural cells. In direct opposition to what was observed 
under FBS differentiation, the use of the HCN inhibitor 
during differentiation did not improve the extent of neu-
ral differentiation. These data may indicate altered differ-
entiation capacity in response to ZD7288 treatment, or 
the emergence of subpopulations differentially respon-
sive to the compound.
Discussion
We have shown that treatment of mouse embryonic stem 
cells with the HCN channel family inhibitor ZD7288 
results in longer cell cycle transit time. Analysis of cell 
cycle phase distribution showed that the relative num-
ber of cells in the G2/M phase declined upon treatment, 
while the S phase fraction increased, indicating a relative 
lengthening of the G1 and S phases with no change in 
G2/M due to treatment.
The HCN blocker-induced increase in S-phase resi-
dence time was not due to accumulation of cells in either 
early or late S, arguing against the requirement for HCN 
activity for S to G2/M progression proposed by Lau et al. 
Fig. 2 S-phase lengthening is not mediated by increased gamma-
H2AX or altered S-phase progression, but is accompanied by reduced 
nucleoside incorporation. Control cells and cells treated with ZD7288 
for 5 days were stained for gammaH2AX (a), with no difference in 
staining intensity (Student’s t-test; not significant; n = 3) (b). Cells 
grown in bulk with and without the addition of ZD7288 were pulsed 
with 10 μM EdU prior to fixation and stained for flow cytometric 
analysis. Treated cells incorporated less EdU (p < 0.05, n = 3) (c). 
Cells grown adherently for 4 days in control or ZD7288 conditions 
were also pulsed and stained for EdU (d), confirming lower levels of 
incorporation. Cells with EdU incorporation pattern typical of early 
S-phase (d, star and inset) and mid-late S-phase (d, arrowhead and 
inset) in both conditions were counted (e) with similar distribution of 
cells between early and late S under both conditions (Student’s t-test; 
not significant; n = 3)
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as the underlying cause of the observed S-phase accumu-
lation. Our experiments showing decreased EdU incor-
poration rather suggest a slowdown in incorporation of 
new nucleosides, whether due to slowed replication or 
impaired import, resulting in slower progression through 
the entire S-phase. The fact that both S and G1 phases 
were lengthened, and to a similar degree, argues that 
HCN blocker affects events critical in both phases. Two 
intriguing possibilities are nutrient import and chroma-
tin folding. The 3D structure of the DNA and its organi-
zation on scaffolding proteins has important implications 
for allowing or impeding access of transcriptional and 
Fig. 3 HCN blocker treatment reduced colony formation frequency but did not induce differentiation. mESC plated at subclonal density were 
allowed to form colonies in control or ZD7288-containing media for 5 days and number of colonies per well was counted (Mann Whitney test; 
p < 0.05; n = 6) (a). Morphology was scored and fraction of rugged colonies calculated (Student’s t-test; p < 0.05; n = 6) (b). At the same time point, 
RNA was collected for qPCR analysis of pluripotency marker expression, which was unchanged (Student’s t-test; not significant; n = 3) (c). Finally, 
fixed cell were stained for pluripotency marker expression, with cells in both culture conditions showing expression (d)
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replication machinery to the DNA, and has been shown 
to be sensitive to its ionic environment, especially with 
regard to mono- and divalent cation concentrations 
(Strick et al. 2001). Nutrient import, on the other hand, is 
known to occur via sodium-coupled co- and symporters 
for a number of critical molecules, such as glucose (Chen 
et  al. 2015a), nucleosides (Choi and Berdis 2012), and 
amino acids (Bror 2014). HCN channels carry cation cur-
rents and are instrumental in regulating sodium fluxes 
during action potentials in electrically active cells (Biel 
et al. 2009), and could thus play a role in sodium home-
ostasis in ESCs, influencing one or both of the above. 
Interestingly, ZD7288 has also been shown to inhibit 
the voltage-activated Nav1.4 sodium channels (Wu et al. 
2012), although these channels have not been detected in 
ESCs (Wang et al. 2005).
Regardless of the underlying cause, the observed 
significant slowdown in cell cycle progression can be 
expected to compromise self-renewal. However, we 
did not observe this in our study, with both treated and 
untreated cells expressing the core pluripotency mark-
ers to similar degree. In fact, significant variation in dou-
bling time of multiple ESC lines stemming from variation 
in culture conditions has previously been reported, with 
cell cycle transit times varying from as short as 13 h to as 
long as 34 h (Tamm et al. 2013). Despite the difference, 
ESCs grown in all culture conditions have been shown 
to retain their stem cell properties and could contribute 
to chimeras (Andang et al. 2008b; Ying et al. 2008; Smith 
1991), indicating that a prolonged doubling time does 
not lead to loss of stem cell potential per se, and sup-
porting our findings that pluripotency marker expres-
sion is unchanged when doubling time is increased as a 
response to treatment.
Interestingly, our data show that spontaneous differ-
entiation using serum, even to ectodermal lineages, but 
not directed differentiation to neuroectoderm in defined 
medium, was improved when ZD7288 was added to 
culture media. The ability of ZD7288-treated cell to 
upregulate markers from all lineages in response to FBS 
differentiation indicates that the differentiation poten-
tial of the cells is not skewed by the treatment, further 
supporting our finding that stemness properties are not 
perturbed by the HCN blocker. The observed difference 
in the functional outcomes of ZD7288 treatment under 
the two differentiation conditions could be due to a num-
ber of different factors. It is possible that the differenti-
ated progeny responds differently to HCN block in the 
Fig. 4 Administration of ZD7288 facilitated differentiation in a protocol-dependent manner. Relative expression levels of pluripotency genes (a) 
and a panel of differentiation genes (b) in cells spontaneously differentiated using FBS. Relative expression levels of pluripotency genes (c) and 
differentiation genes (d) using neurodifferentiation protocol. Ct values were normalized to Tbp expression. Student’s t-test; * p < 0.05; ** p < 0.01; *** 
p < 0.001, n.s. not significant; n = 3
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two conditions, and has a growth advantage over undif-
ferentiated ESCs in FBS but not in neural differentiation, 
resulting in higher degree of differentiation in the FBS 
culture treated with ZD7288.
A more intriguing possibility to consider is the interac-
tion of serum and ion modulation in regulating the cell 
cycle and thereby differentiation propensity. Whereas we 
observed a G1 lengthening as a response to treatment in 
maintenance conditions, this was not reported in previ-
ously published work. One key difference between our 
study and the earlier study by Lau et al. are media com-
ponents, with us using serum-free media in contrasts 
to FBS supplemented media used previously. Serum is 
a potent modulator of the length of the cell cycle, and 
the G1 in particular. When looking at cell cycle profiles 
and doubling times of cells grown in serum-free condi-
tions, such as in our experiments here, and previously 
published data for FBS supplemented conditions (Sava-
tier et al. 2002; Jovic et al. 2013), the calculated S-phase 
lengths are similar at around 11 h (70 % of 16 h with FBS, 
38  % of 28  h in serum-free) while the G1 is extended 
nearly threefold to 9 h in the absence of FBS (20 % of 16 h 
with FBS, 35 % of 28 h in serum-free). The longer G1 in 
serum-free cultured ESCs could impose drastically differ-
ent requirements for HCN function than the short G1 in 
FBS cultured cell, especially if the channel family plays a 
role in regulating nutrient transport and biomass growth. 
In such a case, cells under HCN block face an entirely dif-
ferent cell cycle landscape depending on the presence or 
absence of serum in culture medium.
It has previously been discussed that the relative ratio 
of G1:S length may be critical for pluripotency mainte-
nance, with a lower ratio being linked to improved self-
renewal (Hindley and Philpott 2013). For cells induced 
to differentiate in serum-free conditions under HCN 
block, this ratio is only slightly lowered, and they would 
thus be expected to differentiate with dynamics simi-
lar to untreated cells, consistent with our observations. 
FBS differentiated cells treated with the HCN blocker 
would have a drastically lowered G1:S ratio, which should 
result in improved self-renewal. However, if HCN func-
tion is critical in G1, under HCN blockade the absence 
of a G1/S checkpoint in mESCs could result in preco-
cious S-phase entry accompanied by stress and induction 
of differentiation. In budding yeast, precocious S-phase 
entry induces S-phase lengthening and Rad53 induction, 
which is required for viability maintenance (Sidorova and 
Breeden 2002). CHK2, the mammalian homologue of 
Rad53, is required for histone H2AX phosphorylation in 
mitosis (Tu et al. 2013). This is of particular interest since 
H2AX phosphorylation is necessary for S-phase accumu-
lation of ESCs in response to GABA modulation as previ-
ously described (Andang et al. 2008a).
In future experiments it would be of great interest 
to rigorously test the potential role of HCNs in nutri-
ent transport in ESCs maintained in FBS supplemented 
media. This work supports the idea that G1 lengthen-
ing, in and of itself, does not compromise the pluripotent 
state, and other factors, such as nutrients and permissive 
growth factor signalling, provide an essential layer of fate 
control. Cell cycle effects are an important considera-
tion when designing cell culture protocols for stem cell 
expansion and differentiation, and significant attempts 
are being made to incorporate them into our under-
standing of the path from pluripotency to commitment 
(Li and Kirschner 2014). Mapping the cell fate landscape 
and finding stable states will facilitate controlled, scal-
able and reproducible generation of desired cell types 
using defined, serum-free culture conditions, a necessity 
as cell-based therapies move into the clinic. However, as 
we focus on the signalling pathways that direct the switch 
between desired states, we should not forget the basic cell 
physiological requirements that need to be fulfilled to 
make the transitions.
Conclusion
In this work we show that treatment of mouse ESCs with 
the HCN-channel family blocker ZD7288 induces cell-
cycle lengthening, with an extended G1 and S phases. 
Interestingly, neither the altered cell cycle kinetics nor 
ionic perturbation compromised ESC self-renewal, as 
cells cultured in maintenance media containing 10  μM 
ZD7288 continued to express the core pluripotency fac-
tors both on RNA and protein level. When the effect 
of treatment on differentiation was examined, applica-
tion of the HCN blocker resulted in disparate outcomes 
for spontaneous FBS-driven differentiation, which was 
improved, and FBS-free directed differentiation to the 
neuroectoderm lineage, which was unaffected. Our find-
ings underscore the importance of exploring the effect 
of small molecules on cell cycle progression and differ-
entiation in a variety of culture contexts, and especially 
in serum-free culture conditions, which are of particular 
interest for further clinical development.
Methods
Cell culture
R1/E mouse embryonic stem cell line was purchased 
from ATCC (lot number: 3314644) and cultured as pre-
viously described (Andang et  al. 2008b). In brief, cells 
were seeded at 7.5  ×  103  cells/ml in flasks for suspen-
sion culture or on laminin coated tissue culture plates 
for adherent culture (3  ml/well of 6-well plate, 0.5  ml/
well of 24-well plate). Maintenance media consisted of 
DMEM/F12 (Gibco) supplemented with N2 media sup-
plement (Gibco), HEPES (Gibco), beta-mercaptoethanol 
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(Gibco), bFGF (R&D systems) and LIF (Millipore). Cells 
were grown at 37 °C, 20 % oxygen and split every 4 days 
using TrypLE Express (Gibco). HCN3 activity was inhib-
ited by applying a specific small molecule inhibitor of the 
channel family, ZD7288 (Tocris), at a concentration of 
10 μM in culture medium. Control and treated cells were 
counted and viability assessed at split using the Nucle-
oCounter NC-3000 (Chemometec), and doubling time 
calculated using exponential regression in GraphPad 
Prism 6 (GraphPad Software Inc.). Single cells were fixed 
with 1 % PFA at RT for 15′ for flow cytometry analysis. 
For EdU incorporation, single cell suspension or adher-
ent cells were incubated with EdU (Molecular Probes, 
product number: A10044) for 15′ prior to PFA fixation.
Colony formation assay
To assay colony formation cells were plated on laminin 
coated 6-well/24-well tissue culture plates at 3  ×  102 
cells/cm2. Colonies were allowed to grow with or with-
out HCN3 inhibition for 5 days, at which point cells were 
fixed with 4  % PFA for 15′ at RT. For colony formation 
frequency, plates were stained for ALP activity (45′ incu-
bation at RT in Whatman filtered solution of 0.01 g naph-
tol AS MX-PO4 (Sigma), 0.06 g red violet LB salt (Sigma), 
400uL N,N-dimethylformamide in 50 ml 0.1 M Tris-HCl, 
pH8.3) and were imaged using the CellObserver (Zeiss) 
microscopy system, the number of colonies per well was 
counted manually and morphology scored. For marker 
expression, cells were grown on coverslips, stained, 
mounted on glass slides (VWR) using fluorescence 
mounting medium (Dako) and imaged on Zeiss LSM-710 
confocal microscope.
Differentiation studies
For differentiation studies cells were plated on laminin 
coated 24-well tissue culture plates at 1.5 × 104 cells/cm2. 
FBS differentiation was carried out in DMEM/F12 con-
taining HEPES, Glutamax (Gibco), and 15 % FBS (Gibco). 
Differentiation to the neural lineage was carried out in 
maintenance media supplemented with B27 (Gibco) and 
lacking bFGF and LIF, as previously described (Ying and 
Smith 2003). Media was changed every other day and 
RNA was collected 5 days after differentiation induction.
Gene expression analysis
RNA from treated and untreated cells was collected 
and isolated using the Qiagen mini kit (Qiagen). 500 ng 
of total RNA was reversed transcribed (Applied Bio-
systems) and cDNA was used for qPCR reactions using 
SYBR green PCR master mix (Invitrogen) run on 7500 
Fast Real-Time PCR system (Applied Biosystems). Tbp 
was used as the housekeeping gene reference. Primers 
sequences can be found in Additional file 1: Table S1.
Antibody staining
Following PFA fixation cells were incubated for 1 h at RT 
with 1 % BSA and 0.1 % Tween-20 in PBS to permeabilize 
and block. Primary antibodies were diluted in the blocking 
solution and applied overnight at 4 °C. Cells were washed 
2 times in PBS and species-matched secondary antibod-
ies diluted in blocking solution was applied for 1 h at RT. 
Cells were incubated in 10 μM DAPI in PBS for 15′ at RT, 
washed twice and either mounted or analyzed using CyAN 
ADP flowcytometer (Beckman-Coulter). List of antibodies 
used can be found in Additional file 1: Table S2.
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